001     141369
005     20240416115859.0
024 7 _ |a 10.1186/s41021-017-0078-8
|2 doi
024 7 _ |a pmid:28680508
|2 pmid
024 7 _ |a pmc:PMC5493842
|2 pmc
024 7 _ |a 1880-7046
|2 ISSN
024 7 _ |a 1880-7062
|2 ISSN
024 7 _ |a altmetric:22313591
|2 altmetric
037 _ _ |a DZNE-2020-07691
041 _ _ |a English
082 _ _ |a 690
100 1 _ |a Anwarullah, Anwarullah
|0 P:(DE-2719)9000009
|b 0
|e First author
|u dzne
245 _ _ |a Further evidence for the association of CYP2D6*4 gene polymorphism with Parkinson's disease: a case control study.
260 _ _ |a [London]
|c 2017
|b BioMed Central
264 _ 1 |3 online
|2 Crossref
|b Springer Science and Business Media LLC
|c 2017-07-01
264 _ 1 |3 print
|2 Crossref
|b Springer Science and Business Media LLC
|c 2017-12-01
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1713191824_9659
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Genetic and environmental risk factors play an important role for the susceptibility to sporadic Parkinson's disease (PD). It was hypothesized that a splice variant of the CYP2D6 gene (CYP2D6*4 allele) is associated with PD because it alters the ability to metabolize toxins and in particular neurotoxins. CYP2D6 codes for the drug metabolizing enzyme debrisoquine 4-hydroxylase. The CYP2D6*4 variant results in an undetectable enzyme activity and consequently in a reduction in metabolism of some toxins.Some of agricultural chemicals have neurotoxic potential and CYP2D6 is involved in their detoxification. Thus, we conducted a case control study to investigate the association of the CYP2D6*4 with PD in a Pakistani subpopulation that is known to be exposed to high levels of some agricultural pesticides, insecticides and herbicides.We found a significantly higher allele and genotype frequency of the CYP2D6*4 variant in 174 sporadic PD patients when compared to 200 controls. In addition, there was a trend to an earlier age of PD onset and a tremor dominant phenotype in CYP2D6*4 variant carriers.Our data provide further evidence that a poor metabolizer status may increase the risk to develop PD especially in populations that are exposed to environmental toxins.
536 _ _ |a 341 - Molecular Signaling (POF3-341)
|0 G:(DE-HGF)POF3-341
|c POF3-341
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Aslam, Muhammad
|0 P:(DE-2719)2810579
|b 1
|u dzne
700 1 _ |a Badshah, Mazhar
|b 2
700 1 _ |a Abbasi, Rashda
|b 3
700 1 _ |a Sultan, Aneesa
|b 4
700 1 _ |a Khan, Kafaitullah
|b 5
700 1 _ |a Ahmad, Nafees
|b 6
700 1 _ |a Engelhardt, Jakob
|0 P:(DE-2719)2810460
|b 7
|e Last author
|u dzne
773 1 8 |a 10.1186/s41021-017-0078-8
|b : Springer Science and Business Media LLC, 2017-07-01
|n 1
|p 18
|3 journal-article
|2 Crossref
|t Genes and Environment
|v 39
|y 2017
|x 1880-7062
773 _ _ |a 10.1186/s41021-017-0078-8
|g Vol. 39, no. 1, p. 18
|0 PERI:(DE-600)2269162-5
|n 1
|q 39:1<18
|p 18
|t Genes and environment
|v 39
|y 2017
|x 1880-7062
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/141369/files/DZNE-2020-07691.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/141369/files/DZNE-2020-07691.pdf?subformat=pdfa
856 7 _ |2 Pubmed Central
|u http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493842
909 C O |o oai:pub.dzne.de:141369
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)9000009
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)2810579
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 7
|6 P:(DE-2719)2810460
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-341
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Molecular Signaling
|x 0
914 1 _ |y 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-03-30
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-03-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-03-30
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b GENES ENVIRON : 2021
|d 2023-03-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2021-02-14T16:20:33Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-03-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-03-30
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2023-03-30
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Blind peer review
|d 2021-02-14T16:20:33Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-03-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2021-02-14T16:20:33Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-03-30
920 1 _ |0 I:(DE-2719)1013023
|k AG Engelhardt
|l Synaptic Signalling and Neurodegeneration
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1013023
980 1 _ |a FullTexts
999 C 5 |9 -- missing cx lookup --
|a 10.1016/S0896-6273(03)00568-3
|2 Crossref
|o 10.1016/S0896-6273(03)00568-3
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.tig.2015.01.004
|2 Crossref
|o 10.1016/j.tig.2015.01.004
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.nbd.2012.06.025
|2 Crossref
|o 10.1016/j.nbd.2012.06.025
999 C 5 |9 -- missing cx lookup --
|a 10.1126/science.286.5439.487
|2 Crossref
|o 10.1126/science.286.5439.487
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s11095-010-0157-z
|2 Crossref
|o 10.1007/s11095-010-0157-z
999 C 5 |9 -- missing cx lookup --
|a 10.1016/S0006-2952(98)00142-7
|2 Crossref
|o 10.1016/S0006-2952(98)00142-7
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neurobiolaging.2011.08.014
|2 Crossref
|o 10.1016/j.neurobiolaging.2011.08.014
999 C 5 |9 -- missing cx lookup --
|a 10.1097/00008571-199812000-00003
|2 Crossref
|o 10.1097/00008571-199812000-00003
999 C 5 |y 2013
|2 Crossref
|o Y Lu 2013
999 C 5 |9 -- missing cx lookup --
|a 10.1159/000072926
|2 Crossref
|o 10.1159/000072926
999 C 5 |y 2007
|2 Crossref
|o J Sistonen 2007
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neuro.2004.07.010
|2 Crossref
|o 10.1016/j.neuro.2004.07.010
999 C 5 |y 2015
|2 Crossref
|o L Linder 2015
999 C 5 |9 -- missing cx lookup --
|a 10.1080/10599240801986215
|2 Crossref
|o 10.1080/10599240801986215
999 C 5 |9 -- missing cx lookup --
|a 10.1002/ana.410360119
|2 Crossref
|o 10.1002/ana.410360119
999 C 5 |9 -- missing cx lookup --
|a 10.1001/archneur.62.1.91
|2 Crossref
|o 10.1001/archneur.62.1.91
999 C 5 |9 -- missing cx lookup --
|a 10.1097/EDE.0b013e3181c15ec6
|2 Crossref
|o 10.1097/EDE.0b013e3181c15ec6
999 C 5 |9 -- missing cx lookup --
|a 10.1080/009841000156907
|2 Crossref
|o 10.1080/009841000156907
999 C 5 |9 -- missing cx lookup --
|a 10.1289/ehp.8095
|2 Crossref
|o 10.1289/ehp.8095
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.tox.2006.04.024
|2 Crossref
|o 10.1016/j.tox.2006.04.024
999 C 5 |9 -- missing cx lookup --
|a 10.1016/S0378-4274(00)00221-6
|2 Crossref
|o 10.1016/S0378-4274(00)00221-6
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s00204-003-0452-0
|2 Crossref
|o 10.1007/s00204-003-0452-0
999 C 5 |9 -- missing cx lookup --
|a 10.2741/2758
|2 Crossref
|o 10.2741/2758
999 C 5 |9 -- missing cx lookup --
|a 10.1002/ana.20051
|2 Crossref
|o 10.1002/ana.20051
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.envint.2007.07.012
|2 Crossref
|o 10.1016/j.envint.2007.07.012
999 C 5 |9 -- missing cx lookup --
|a 10.1007/978-3-319-34451-5
|2 Crossref
|o 10.1007/978-3-319-34451-5
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s10661-009-0995-5
|2 Crossref
|o 10.1007/s10661-009-0995-5
999 C 5 |y 2008
|2 Crossref
|o DA Khan 2008
999 C 5 |y 1989
|2 Crossref
|t Molecular cloning: a laboratory manual
|o J Sambrook Molecular cloning: a laboratory manual 1989
999 C 5 |9 -- missing cx lookup --
|a 10.1212/WNL.40.10.1529
|2 Crossref
|o 10.1212/WNL.40.10.1529
999 C 5 |9 -- missing cx lookup --
|a 10.1373/49.4.542
|2 Crossref
|o 10.1373/49.4.542
999 C 5 |9 -- missing cx lookup --
|a 10.1016/0009-9236(95)90154-X
|2 Crossref
|o 10.1016/0009-9236(95)90154-X
999 C 5 |9 -- missing cx lookup --
|a 10.1006/bmme.1995.1012
|2 Crossref
|o 10.1006/bmme.1995.1012
999 C 5 |9 -- missing cx lookup --
|a 10.1248/bpb.29.1655
|2 Crossref
|o 10.1248/bpb.29.1655
999 C 5 |9 -- missing cx lookup --
|a 10.1046/j.1365-2125.2003.01883.x
|2 Crossref
|o 10.1046/j.1365-2125.2003.01883.x
999 C 5 |9 -- missing cx lookup --
|a 10.1080/10934529.2014.854687
|2 Crossref
|o 10.1080/10934529.2014.854687
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.envint.2010.10.007
|2 Crossref
|o 10.1016/j.envint.2010.10.007
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s10661-009-1107-2
|2 Crossref
|o 10.1007/s10661-009-1107-2
999 C 5 |9 -- missing cx lookup --
|a 10.5607/en.2012.21.3.123
|2 Crossref
|o 10.5607/en.2012.21.3.123
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.ejphar.2013.12.025
|2 Crossref
|o 10.1016/j.ejphar.2013.12.025
999 C 5 |9 -- missing cx lookup --
|a 10.1074/jbc.M112.402123
|2 Crossref
|o 10.1074/jbc.M112.402123


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21